PharmiWeb
ViiV Healthcare announces data demonstrating Dovato (DTG/3TC) is highly effective in treatment-naive people with advanced HIV
ViiV Healthcare, the global specialist HIV company majority owned by GSK, with Pfizer and Shionogi as shareholders, today announced 48-week findings from the DOLCE study, sponsored by Fundación ...
1 day ago